查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041723

周邊血管介入市場預測—按產品、手術、應用、最終用戶和地區分類的全球分析—2034年

Peripheral Interventions Market Forecasts to 2034 - Global Analysis By Product, Procedures, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球周邊血管介入市場預計到 2026 年將達到 119 億美元，並在預測期內以 10.2% 的複合年成長率成長，到 2034 年達到 259 億美元。

「周邊介入治療」是指用於治療心臟和大腦以外的動脈和靜脈疾病（即周邊血管系統疾病）的醫療程序。在周邊介入治療中，醫護人員會採用多種微創技術，例如血管成形術、支架置入術、動脈粥狀硬化斑塊切除術和血栓切除術。因此，這些手術是傳統開放性手術的有效替代方案，可縮短恢復時間並降低風險。

據美國心臟協會稱，加拿大患者每年在治療和診斷周邊動脈疾病方面大約花費 4,600 美元。

醫療費用不斷上漲

先進設備的普及提高了這些手術的精準度和有效性，吸引了許多醫療專業人員，並增強了患者對這些先進治療方法的信心。在全球範圍內，尤其是在已開發國家，醫療保健領域不斷增加的資金投入對醫療技術和治療方法的進步起著至關重要的作用。此外，這種資金支持也促進了研發，推動了周邊血管介入領域的持續創新，進而推動了市場成長。

高成本

用於周邊介入治療的醫療器材與設備高成本，這主要是因為合規生產、研發和相關成本高昂。血管內超音波和血管造影術等先進影像技術的應用也推高了價格。此外，進行周邊介入治療所需的知識和培訓成本也阻礙了市場成長。

優惠的還款政策

能夠充分涵蓋周邊介入治療相關成本的報銷方案，獎勵醫療機構提供這些先進的治療手段，並確保患者獲得治療。包括周邊介入治療技術製造商和研發人員在內的相關人員，也能從有利的報銷政策中受益。此外，當報銷金額與這些介入治療的價值相符時，會鼓勵醫療機構投資於尖端技術和專業人才，最終促進外周介入治療的普及，並顯著推動市場成長。

缺乏意識和教育

醫生和醫療保健專業人員可能對最新進展了解不足，導致周邊血管介入治療作為一種治療選擇缺乏認知和應用。有限的患者教育和宣傳宣傳活動加劇了症狀識別困難、診斷延誤以及治療延誤。此外，這種知識匱乏使情況更加複雜，並阻礙了市場成長，因為患者可能會選擇傳統治療方法或放棄治療。

新冠疫情的影響

新冠疫情對周邊血管介入市場造成了顯著的負面影響。為遏制病毒傳播而實施的限制措施，例如封鎖和擇期手術限制，導致非緊急周圍血管介入手術數量大幅下降。對醫院感染的擔憂促使患者推遲或取消手術，進而導致對周圍血管介入服務和設備的需求下降。此外，全球供應鏈和生產流程的中斷也阻礙了市場擴張。

在預測期內，動脈粥狀硬化斑塊切除術器械領域預計將成為最大的細分市場。

由於能夠清除血管內的動脈粥狀硬化斑塊、改善血流並降低缺血和截肢等併發症的風險，動脈粥狀硬化斑塊切除術裝置預計將佔據最大的市場佔有率。此領域採用多種技術，包括旋轉式、軌道式、雷射式和定向式動脈動脈粥狀硬化斑塊切除術切除術。此外，與傳統方法相比，該領域對血管壁的損傷更小、治療效果更佳，且在治療複雜動脈病變方面也卓有成效，這些優勢正在推動該領域的成長。

預計在預測期內，靜脈血栓栓塞症細分市場將呈現最高的複合年成長率。

由於靜脈血栓栓塞症領域能夠提供針對靜脈相關血栓形成的醫療程序和干涉措施，預計該領域在預測期內將實現顯著成長。這些干預措施對於預防血栓事件的進展、降低併發症風險以及改善患者整體預後至關重要。此外，利用機械血栓除去裝置物理移除血栓的能力，在最大限度減少創傷的同時提高血栓切除術的有效性，也推動了該領域的擴張。

市佔率最大的地區：

在預測期內，北美佔據了最大的市場佔有率，這主要得益於其強勁的市場環境，包括技術進步、高額的醫療費用支出以及周邊血管疾病盛行率的上升。醫療服務提供者、行業相關人員和研究機構之間的合作確保了新技術和治療方法的持續應用。此外，優惠的報銷政策和積極的監管環境也促進了先進周邊血管介入手術的快速普及，推動了該地區的成長。

複合年成長率最高的地區：

由於周邊血管疾病盛行率不斷上升，預計亞太地區在預測期內將實現強勁成長。中國、日本、印度和澳洲等國家對先進介入治療的需求激增，這主要歸因於人口老化、生活方式改變以及人們對微創治療方法認知的不斷提高。此外，血管成形術、支架置入術術、斑塊動脈粥狀硬化斑塊切除術和血栓切除術等周邊血管介入治療作為傳統外科手術的有效替代方案，正日益受到關注，從而推動了該地區市場的擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球周邊血管介入市場：依產品分類

  • 導管
  • 鞘套
  • 導管導引線
  • 動脈粥狀硬化斑塊切除術裝置
  • 栓塞裝置
  • 支架
    • 裸金屬支架
    • 藥物釋放型支架
  • 下腔靜脈（IVC）
  • 血栓除去裝置
  • 斑塊修飾裝置
  • 血流動力學流速控制裝置
  • 其他產品

第6章 全球周邊血管介入市場：依手術類型分類

  • 腫瘤學技術
  • 胃
  • 神經病學
  • 皮膚護理
  • 輸尿管
  • 腎
  • 肝
  • 其他措施

第7章 全球周邊血管介入市場：依應用分類

  • 靜脈血栓栓塞症
  • 周邊動脈疾病
  • 其他用途

第8章 全球周邊血管介入市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 導管檢查室
  • 其他最終用戶

第9章 全球周邊血管介入市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Boston Scientific Corporation
  • Abbott Laboratories
  • WL Gore & Associates Inc
  • AngioDynamics Inc.
  • Medtronic
  • Teleflex Incorporated
  • Cardinal Health Inc
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • CR Bard Inc.
  • Cook Medical
  • Terumo Interventional Systems Inc
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • St. Jude Medical
Product Code: SMRC24786

According to Stratistics MRC, the Global Peripheral Interventions Market is accounted for $11.9 billion in 2026 and is expected to reach $25.9 billion by 2034 growing at a CAGR of 10.2% during the forecast period. The term "peripheral interventions" describes medical procedures used to treat diseases affecting the arteries and veins that are not part of the heart or brain, or the peripheral vascular system. Medical professionals utilize various minimally invasive techniques during peripheral interventions, such as angioplasty, stent placement, atherectomy, and thrombectomy. Therefore, these procedures often provide effective alternatives to traditional open surgeries, offering quicker recovery times and reduced risks.

According to the American Heart Association, a patient in Canada spends around USD 4,600 per year on treatment and diagnosis of peripheral atrial disease.

Market Dynamics:

Driver:

Growing healthcare expenditure

The availability of cutting-edge tools enhances the precision and efficacy of these procedures, attracting healthcare professionals and fostering patient confidence in these advanced treatment options. Increasing financial investments in healthcare witnessed globally and particularly in developed economies, plays a crucial role in advancing medical technologies and treatment modalities. In addition, this financial support facilitates research and development, leading to continuous innovation in peripheral interventions, which is driving this market size.

Restraint:

High cost

Medical equipment and devices used in peripheral interventions can have high costs because of their expensive manufacturing, research and development in compliance with regulations. Using cutting-edge imaging techniques like intravascular ultrasound and angiography also contributes to the high price. Furthermore, this market size is being hampered by the cost of the knowledge and training needed to carry out peripheral interventions.

Opportunity:

Favorable reimbursement policies

Reimbursement structures that adequately cover the costs associated with peripheral interventions incentivize healthcare providers to offer these advanced procedures, ensuring accessibility for patients. Industry stakeholders, including manufacturers and developers of peripheral intervention technologies, also benefit from favorable reimbursement policies. Furthermore, when reimbursement aligns with the value of these interventions, it encourages healthcare facilities to invest in state-of-the-art technologies and skilled personnel, ultimately promoting the adoption of peripheral interventions and significantly propelling market growth.

Threat:

Lack of awareness and education

Physicians and healthcare providers may not be fully aware of the latest advancements, which results in a lack of awareness and underutilization of peripheral interventions as a treatment option. Limited patient education and awareness campaigns contribute to the under-recognition of symptoms, delayed diagnosis, and subsequent treatment. In addition, this lack of knowledge may lead patients to opt for traditional treatment methods or remain untreated altogether, making it complex and hampering market growth.

Covid-19 Impact

The COVID-19 pandemic has had a notable negative impact on the peripheral intervention market. The restrictions imposed to curb the spread of the virus, such as lockdowns and limitations on elective procedures, led to a significant decline in the number of non-urgent peripheral interventions. Fear of contracting the virus in hospital settings caused patients to postpone or cancel procedures, which reduced the demand for peripheral intervention services and devices. Moreover, disruptions in the global supply chain and manufacturing processes hampered market expansion.

The atherectomy devices segment is expected to be the largest during the forecast period

The atherectomy devices segment is estimated to hold the largest share due to the fact that it involves the removal of atherosclerotic plaque from blood vessels, facilitates improved blood flow, and reduces the risk of complications such as ischemia and limb-threatening conditions. It utilizes various techniques, including rotational, orbital, laser, and directional atherectomy. Additionally, their effectiveness in treating complex arterial lesions while offering advantages such as reduced trauma to the vessel walls and enhanced outcomes compared to traditional methods driving this segment's growth.

The venous thromboembolism segment is expected to have the highest CAGR during the forecast period

The venous thromboembolism segment is anticipated to have lucrative growth during the forecast period due to its ability to address medical procedures and interventions aimed at managing conditions involving blood clots within the veins. These interventions are crucial for preventing the progression of thrombotic events, reducing the risk of complications, and improving overall patient outcomes. Furthermore, mechanical thrombectomy devices may be employed to physically remove the clot, enhancing the efficacy of clot removal while minimizing invasiveness, which is boosting segment expansion.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to a robust landscape characterized by technological advancements, high healthcare expenditure, and a growing prevalence of peripheral vascular diseases. Collaborations between healthcare providers, industry stakeholders, and research institutions ensure a continuous influx of novel technologies and treatment modalities. Furthermore, favorable reimbursement policies and a proactive regulatory environment contribute to the rapid adoption of advanced peripheral intervention procedures, which are driving this region's growth.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period due to a rising prevalence of peripheral vascular diseases. Countries like China, Japan, India, and Australia are witnessing a surge in demand for advanced interventional procedures due to factors such as aging populations, lifestyle changes, and heightened awareness of minimally invasive treatment options. Additionally, peripheral interventions, including angioplasty, stenting, atherectomy, and thrombectomy, are gaining traction as viable alternatives to traditional surgical approaches, which are boosting this region's expansion.

Key players in the market

Some of the key players in the Peripheral Interventions Market include Boston Scientific Corporation, Abbott Laboratories, W. L. Gore & Associates Inc, AngioDynamics Inc., Medtronic, Teleflex Incorporated, Cardinal Health Inc, Terumo Corporation, Biotronik SE & Co. KG, C.R. Bard Inc., Cook Medical, Terumo Interventional Systems Inc, Becton Dickinson and Company, B. Braun Melsungen AG and St. Jude Medical.

Key Developments:

In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.

In November 2023, Terumo announced the launch of Insulin Syringe, Sterile delivery device for patients requiring regular insulin injections, thereby raising the bar for patient comfort and therapy compliance.

In June 2023, the American Diabetes Association(R) (ADA) and Abbott announced a collaboration aimed at better understanding how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.

In June 2023, Terumo Aortic announced the launch of the company's global Post-Approval Study (PAS) known as EXTEND for Thoraflex Hybrid, the only Frozen Elephant Trunk (FET) device approved by the US Food and Drug Administration (FDA) for the treatment of patients with complex aortic arch disease.

Products Covered:

  • Catheters
  • Sheath
  • Guide Wires
  • Atherectomy Devices
  • Embolic Devices
  • Stents
  • Inferior Vena Cava (IVC)
  • Thrombectomy Devices
  • Plaque Modification Device
  • Hemodynamic Flow Alteration Devices
  • Other Products

Procedures Covered:

  • Oncology Procedures
  • Gastric
  • Neurology
  • Skin Procedures
  • Uteral
  • Renal
  • Hepatic
  • Other Procedures

Applications Covered:

  • Venous Thromboembolism
  • Peripheral Artery Disease
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Catheterization Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Peripheral Interventions Market, By Product

  • 5.1 Introduction
  • 5.2 Catheters
  • 5.3 Sheath
  • 5.4 Guide Wires
  • 5.5 Atherectomy Devices
  • 5.6 Embolic Devices
  • 5.7 Stents
    • 5.7.1 Bare Metal Stents
    • 5.7.2 Drug-Eluting Stents
  • 5.8 Inferior Vena Cava (IVC)
  • 5.9 Thrombectomy Devices
  • 5.10 Plaque Modification Device
  • 5.11 Hemodynamic Flow Alteration Devices
  • 5.12 Other Products

6 Global Peripheral Interventions Market, By Procedures

  • 6.1 Introduction
  • 6.2 Oncology Procedures
  • 6.3 Gastric
  • 6.4 Neurology
  • 6.5 Skin Procedures
  • 6.6 Uteral
  • 6.6 Renal
  • 6.7 Hepatic
  • 6.8 Other Procedures

7 Global Peripheral Interventions Market, By Application

  • 7.1 Introduction
  • 7.2 Venous Thromboembolism
  • 7.3 Peripheral Artery Disease
  • 7.4 Other Applications

8 Global Peripheral Interventions Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Catheterization Laboratories
  • 8.5 Other End Users

9 Global Peripheral Interventions Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Boston Scientific Corporation
  • 11.2 Abbott Laboratories
  • 11.3 W. L. Gore & Associates Inc
  • 11.4 AngioDynamics Inc.
  • 11.5 Medtronic
  • 11.6 Teleflex Incorporated
  • 11.6 Cardinal Health Inc
  • 11.7 Terumo Corporation
  • 11.8 Biotronik SE & Co. KG
  • 11.9 C.R. Bard Inc.
  • 11.10 Cook Medical
  • 11.11 Terumo Interventional Systems Inc
  • 11.12 Becton Dickinson and Company
  • 11.13 B. Braun Melsungen AG
  • 11.14 St. Jude Medical

List of Tables

  • Table 1 Global Peripheral Interventions Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Peripheral Interventions Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Peripheral Interventions Market Outlook, By Catheters (2023-2034) ($MN)
  • Table 4 Global Peripheral Interventions Market Outlook, By Sheath (2023-2034) ($MN)
  • Table 5 Global Peripheral Interventions Market Outlook, By Guide Wires (2023-2034) ($MN)
  • Table 6 Global Peripheral Interventions Market Outlook, By Atherectomy Devices (2023-2034) ($MN)
  • Table 7 Global Peripheral Interventions Market Outlook, By Embolic Devices (2023-2034) ($MN)
  • Table 8 Global Peripheral Interventions Market Outlook, By Stents (2023-2034) ($MN)
  • Table 9 Global Peripheral Interventions Market Outlook, By Bare Metal Stents (2023-2034) ($MN)
  • Table 10 Global Peripheral Interventions Market Outlook, By Drug-Eluting Stents (2023-2034) ($MN)
  • Table 11 Global Peripheral Interventions Market Outlook, By Inferior Vena Cava (IVC) (2023-2034) ($MN)
  • Table 12 Global Peripheral Interventions Market Outlook, By Thrombectomy Devices (2023-2034) ($MN)
  • Table 13 Global Peripheral Interventions Market Outlook, By Plaque Modification Device (2023-2034) ($MN)
  • Table 14 Global Peripheral Interventions Market Outlook, By Hemodynamic Flow Alteration Devices (2023-2034) ($MN)
  • Table 15 Global Peripheral Interventions Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 16 Global Peripheral Interventions Market Outlook, By Procedures (2023-2034) ($MN)
  • Table 17 Global Peripheral Interventions Market Outlook, By Oncology Procedures (2023-2034) ($MN)
  • Table 18 Global Peripheral Interventions Market Outlook, By Gastric (2023-2034) ($MN)
  • Table 19 Global Peripheral Interventions Market Outlook, By Neurology (2023-2034) ($MN)
  • Table 20 Global Peripheral Interventions Market Outlook, By Skin Procedures (2023-2034) ($MN)
  • Table 21 Global Peripheral Interventions Market Outlook, By Uteral (2023-2034) ($MN)
  • Table 22 Global Peripheral Interventions Market Outlook, By Renal (2023-2034) ($MN)
  • Table 23 Global Peripheral Interventions Market Outlook, By Hepatic (2023-2034) ($MN)
  • Table 24 Global Peripheral Interventions Market Outlook, By Other Procedures (2023-2034) ($MN)
  • Table 25 Global Peripheral Interventions Market Outlook, By Application (2023-2034) ($MN)
  • Table 26 Global Peripheral Interventions Market Outlook, By Venous Thromboembolism (2023-2034) ($MN)
  • Table 27 Global Peripheral Interventions Market Outlook, By Peripheral Artery Disease (2023-2034) ($MN)
  • Table 28 Global Peripheral Interventions Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 29 Global Peripheral Interventions Market Outlook, By End User (2023-2034) ($MN)
  • Table 30 Global Peripheral Interventions Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 31 Global Peripheral Interventions Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 32 Global Peripheral Interventions Market Outlook, By Catheterization Laboratories (2023-2034) ($MN)
  • Table 33 Global Peripheral Interventions Market Outlook, By Other End Users (2023-2034) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.